Edison T. Liu is an American chemist who is the former president and CEO of The Jackson Laboratory,and the former director of its NCI-designated Cancer Center (2012-2021). Before joining The Jackson Laboratory,he was the founding executive director of the Genome Institute of Singapore (GIS),chairman of the board of the Health Sciences Authority,and president of the Human Genome Organization (HUGO) (2007-2013). As the executive director of the GIS,he brought the institution to international prominence as one of the most productive genomics institutions in the world.
Brian J. Druker is a physician-scientist at Oregon Health &Science University (OHSU),in Portland,Oregon. He is the director of OHSU's Knight Cancer Institute,JELD-WEN Chair of Leukemia Research,Associate Dean for Oncology in the OHSU School of Medicine,and professor of medicine.
Timothy J. Ley is an American hematologist and cancer biologist. He is the Lewis T. and Rosalind B. Apple Professor of Oncology in the department of medicine,and is chief of the section of stem cell biology in the division of oncology at Washington University in St. Louis. He is a member of the Alvin J. Siteman Cancer Center.
Carlo Gambacorti-Passerini is an Italian oncologist and hematologist known for his contributions to cancer research.
Douglas James Hilton is an Australian molecular biologist. He is the CEO of CSIRO and immediate past Director of the Walter and Eliza Hall Institute of Medical Research in Melbourne,Australia. His research has focused on cytokines,signal transduction pathways and the regulation of blood cell formation (hematopoiesis). Hilton was the President of the Association of the Australian Medical Research Institutes (AAMRI) from 2014-16.
Clara Derber Bloomfield,was an American physician and cancer researcher. Her work focused on the genetic changes that are present in certain types of blood cancers,and how those can be utilized to improve treatment for the affected patients.
The Japanese Foundation for Cancer Research (公益財団法人がん研究会) (JFCR) is a non-profit cancer research organization based in Ariake,Tokyo. The JFCR was founded in 1908 as the first Japanese organization specializing in cancer by KatsusaburōYamagiwa and his supporters. The Cancer Institute and its attached hospital of JFCR were set up in 1934. The JFCR became a full member of the Union for International Cancer Control in 1968.
Roland Mertelsmann is a German hematologist and oncologist. He was a professor at the Freiburg University Medical Center,Department of Internal Medicine I (Oncology/Hematology). Mertelsmann is known for his scientific works in the fields of hematology,oncology,gene therapy and stem cell transplantation.
Thomas E. Hutson is an American medical oncologist and cancer researcher based in Dallas,Texas. He is the director of Genitourinary Oncology Program and co-director of the Urologic Cancer Research and Treatment Center at Baylor University Medical Center. He is a Professor of Medicine at the Texas A&M Health Science Center College of Medicine and serves as a chair of Genitourinary Research for US Oncology and McKesson.
Azra Raza is the Chan Soon-Shiong Professor of Medicine and Director of the Myelodysplastic Syndrome (MDS) Center at Columbia University. She has previously held positions at Roswell Park Comprehensive Cancer Center,University of Cincinnati,Rush University,and the University of Massachusetts. Raza's research focuses on myelodysplastic syndrome and acute myeloid leukemia.
Steven T. Rosen is the executive vice president and director emeritus of City of Hope's Beckman Research Institute and cancer center. He was previously the provost and chief scientific officer of City of Hope National Medical Center in Duarte,California. In addition to previously directing City of Hope's Comprehensive Cancer Center,he also led the Beckman Research Institute at City of Hope and the Irell &Manella Graduate School of Biological Sciences. Previously (1989-2014),Rosen was the director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University,which was awarded comprehensive cancer center status by the National Cancer Institute (NCI) in 1997.
Maha H. Hussain is the Genevieve E. Teuton Professor of Medicine and deputy director of the Lurie Comprehensive Cancer Center at Northwestern University's Feinberg School of Medicine. She is an oncologist focusing on genitourinary cancers.
Ravi Salgia is a translational thoracic oncologist,clinician/scientist,and academician.
David R. Gius is an American physician-scientist the Zell Family Scholar Professor,Women's Cancer Research Program director,and Vice Chair of Translational Research at Northwestern University's Feinberg School of Medicine Department of Radiation Oncology and Pharmacology. His research focuses into the mechanistic connection between aging,cellular and/or mitochondrial metabolism,and carcinogenesis focusing on the Sirtuin gene family.
The Robert H. Lurie Comprehensive Cancer Centerof Northwestern University is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center located on Northwestern Memorial Hospital's downtown medical campus in the Streeterville neighborhood of Chicago,Illinois,United States. One of two NCI-designated cancer centers in Illinois,Lurie Cancer Center's physicians and scientists hold faculty appointments within the Feinberg School of Medicine,Weinberg College of Arts and Sciences,McCormick School of Engineering and Applied Sciences,and other academic units across Northwestern University. Together,they bring their combined knowledge and expertise to patients at Northwestern Memorial Hospital,Ann &Robert H. Children's Hospital of Chicago,Shirley Ryan AbilityLab and the Jesse Brown VA Medical Center. Additionally,Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network and a member of the Big Ten Cancer Research Consortium.
Stephan A. Grupp is an American pediatric oncologist. He is the Chief of the Cell Therapy and Transplant Section in the Division of Oncology and Director of the Cancer Immunotherapy Program at the Children's Hospital of Philadelphia and Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. In 2019,Grupp was elected a Member of the National Academy of Medicine.
Vadim Backman is an American biomedical engineer and the Sachs Family Professor of biomedical engineering at the Robert R. McCormick School of Engineering and Applied Science at Northwestern University. He is also a Professor of Medicine (Hematology/Oncology) and Professor of Biochemistry and Molecular Genetics at Feinberg School of Medicine and is the Associate Director of Research Technology and Infrastructure and Program Leader in Cancer and Physical Sciences at Robert H. Lurie Comprehensive Cancer Center.
Christopher Hourigan is a physician-scientist known for work on measurable residual disease in acute myeloid leukemia.
Bob Löwenberg is a clinical hematologist/investigator. He is Professor of Hematology at Erasmus University Rotterdam.
Jonathan D. Licht is an American physician who has served as director of the University of Florida Health Cancer Center since 2015,holding The Marshall E. Rinker Sr. Rinker Chair. Licht led the UF Health Cancer Center to achieve designation from the National Cancer Institute in June 2023.
